Fundz

Invitae Corp reported raising $6.01 Million in an initial SEC Form D filing, from an offering of $6.01 Million

PRIVATEJun 15, 2017

Amount Raised

$6.01 Million

$6.01 Million sold, per SEC Form D (first sale Jun 15, 2017)

Round Type

Venture

San FranciscoBiotechnology

Quick answer

Invitae raised $6.01 Million in a funding round, dated June 15, 2017. Invitae is based in San Francisco, California, United States.

How much did Invitae raise?
Invitae raised $6.01 Million in a funding round on June 15, 2017.
What does Invitae do?
Invitae is a leading medical genetics company trusted by millions of patients and their providers to deliver timely genetic information using digital technology.
Where is Invitae based and how big is it?
Invitae is based in San Francisco, California, United States.
Who are the decision-makers at Invitae?
Fundz holds 1 contact at Invitae. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Invitae that raised within 45 days of this round, from Fundz verified event records.

  • CohBar, Inc. raised $5.2M on July 28, 2017.
  • Daré Bioscience, Inc. raised $21M on July 28, 2017.
  • AGRI-NEO INC raised $193K (Pre-Seed) on July 28, 2017.
  • Yarrow Bioscience raised $51M on July 28, 2017.
  • BioMedomics, Inc. raised $530K (Seed) on July 28, 2017.
  • Viome raised $15M on July 28, 2017.

Who to call at Invitae, and when

A new round usually means Invitae is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Invitae raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Invitae, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Invitae. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Invitae

Location

San Francisco, California, United States

About

Invitae is a leading medical genetics company trusted by millions of patients and their providers to deliver timely genetic information using digital technology. We’re working to provide accurate and actionable answers to strengthen medical decision-making for individuals and their families. Invitae's genetics experts apply a rigorous approach to data and research, serving as the foundation of our mission to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Invitae raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts14 people are listed at Invitae. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Invitae's next move

See what Strategic adds

Invitae raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.